Navigation Links
You: Being Beautiful Authors Mehmet Oz, MD, & Michael Roizen, MD, Call Ribose One of the Decade's 'Real Nutritional Heroes'
Date:1/5/2009

MINNEAPOLIS, Jan. 5 /PRNewswire/ -- In their latest book, You: Being Beautiful - The Owner's Manual to Inner and Outer Beauty (Free Press, 2008), co-authors Mehmet Oz, MD and Michael Roizen, MD refer to ribose as one of the decade's "real nutritional heroes" that can "turbo-charge" those who need an energy boost. Ribose is a naturally occurring 5-carbon sugar the body uses to stimulate the production of adenosine triphosphate (ATP) -- an essential energy compound.

Although ribose is produced by the body, this energy molecule cannot be replenished fast enough during certain times of demanding exercise, stress, or as a result of many chronic diseases. When added to foods and dietary supplements, D-Ribose enhances the body's natural process of energy synthesis. It reduces the loss of energy during stress, and accelerates energy and tissue recovery and the management of free radicals.

According to Jacob Teitelbaum, MD, Medical Director of the national Fibromyalgia and Fatigue Centers, Inc., and best-selling author of From Fatigued to Fantastic! (Penguin Group), we are in the midst of a human energy crisis. "We're witnessing an emerging worldwide exhaustion epidemic," said Teitelbaum. "The increased stress of modern life combined with poor sleep and nutrition is being reflected not only in the high levels of fatigue but in the accompanying epidemic of pain currently experienced by one in four Americans along with heart disease, the number one killer in the United States."

Dr. Teitelbaum's research published in the Journal of Alternative and Complementary Medicine (12:9, 2006), found a full two-thirds of his patients reported improvement of their symptoms in the first 12 days following a course of Corvalen(R) D-Ribose treatment. The average improvement in energy was 45 percent and quality of life improved an average of 30 percent. Patients reported less muscle soreness and stiffness, better ability to overcome fatigue, as well as simply feeling better. "Supplemental Corvalen(R) is part of a clinically proven program we've developed that is helping millions of people overcome the debilitating effects of Chronic Fatigue Syndrome and fibromyalgia as well as a general malaise of exhaustion," said Teitelbaum. Corvalen(R) is also used by physicians to treat congestive heart failure and to prepare patients for off-pump bypass surgery(1).

"Bioenergy D-Ribose(TM) also has sweeping applications for healthy people who need more energy every day," said Raj Khankari, Ph.D., CEO of Bioenergy, Inc. "It is already widely used as an effective training and recovery tool by high-performance athletes. We've only scratched the surface on the wide-ranging health and training benefits of this nutritional powerhouse."

Bioenergy, Inc. -- The Ribose Company(TM) -- (http://www.bioenergy.com), recently achieved GRAS (generally recognized as safe) status for D-Ribose from the U.S. Food and Drug Administration. The privately held, Minneapolis-based life sciences company has amassed a large body of scientific literature on the uses of ribose for people across all age and health categories. It has more than 40,000 customers for its proprietary Corvalen(R) products alone, and millions worldwide use Bioenergy D-Ribose(TM) in other functional foods like energy bars (Detour, FastFuel, Marathon) and beverages (SoBe Adrenaline Rush, Vitamin Water, Snapple Antioxidant Water). Currently, Bioenergy D-Ribose(TM) is included as an ingredient in approximately 100 products. The company's core technology lies in the development and commercialization of products based on the physiological benefits of D-Ribose for health and wellness.

    (1) D. Perkowski, MD, S. Wagner, RN, A. Marcus, MD, J. St. Cyr, MD, Ph.D.,
        Saddleback Hospital, Orange Co., CA, "D-Ribose Improves Cardiac
        Indices in Patients Undergoing "Off-Pump" Coronary Arterial
        Revascularization," presented at Academic Surgical Congress, February
        2007.

'/>"/>
SOURCE Bioenergy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. A Scientist Dechipers the Code to Beautiful, Healthy Skin in The New Science of Perfect Skin
2. With the BEAUTIFUL Results, Procoralan* (ivabradine) is the First Antianginal Treatment Shown to Reduce Myocardial Infarction (Heart Attack) and Revascularisation in Stable Coronary Patients
3. PNAS paper and its authors honored for scientific excellence
4. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
5. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
6. Genstar Names Michael Hurt to Its Strategic Advisory Board
7. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
8. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
9. Pharmasset Appoints Michael Rogers as Chief Development Officer
10. The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role of LRRK2 and Alpha-Synuclein Genes in Parkinsons Disease
11. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Pa., Feb. 24, 2017  VWR Corporation (NASDAQ: VWR), the ... laboratory and production customers, today reported its financial results for ... Highlights: 4Q16 record quarterly ... 1.0% on an organic basis. ... an organic basis, while the Americas net sales increased 2.5%, ...
(Date:2/23/2017)... RAFAEL, Calif., Feb. 23, 2017 ... U.S. dollars, except per share data, unaudited)Three Months Ended ... ChangeTotal BioMarin Revenue $   ...   22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced ... for two key immunotherapy technologies from the University ... provides a method to monitor a patient for ... PD-L1 and CTLA-4.  The second license extends the ... patient is likely to have an immune-related adverse ...
(Date:2/23/2017)...  Imanis Life Sciences announced today the launch ... viruses for virotherapy research. These viruses are licensed ... vaccinia virus-based technology platform for research use. ... partnership with Genelux to offer researchers, for the ... in research," said Dr. Kah Whye Peng ...
Breaking Biology Technology:
(Date:2/3/2017)... , Feb. 3, 2017 A new ... Identity Strategy Partners, LLP (IdSP) . Designed to fill ... the complex identity market, founding partners Mark Crego ... 35 combined years just in identity expertise that span ... and non-profit leadership. The Crego-Kephart combined expertise has a ...
(Date:2/1/2017)... 2017 IDTechEx Research, a leading provider of ... the availability of a new report, Sensors for Robotics: Technologies, ... Reading ... ... Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: ...
(Date:1/26/2017)... -- Acuity Market Intelligence today released the 2017 "Ten ... characterizes 2017 as a "breakout" year for biometrics ... new understanding of the potential benefits these technologies ... are often perceived as threats to privacy and ... Acuity Market intelligence. "However, taken together these technologies ...
Breaking Biology News(10 mins):